Cannabis & Wellness

The cannabis giant posts strong Q1 growth and nears profitability, but a widening cash outflow reveals the tough road ahead in a maturing global market.

WM Technology's Q2 results show a puzzling split: higher net income but falling revenue and key metrics. Is this savvy cost-cutting or a sign of deeper trouble?

A strategic merger saves Mississippi’s essential cannabis testing infrastructure, but the consolidation of the state's last two labs reveals the harsh economic realities of a slower-than-expected market.

Cresco Labs posts a 15% revenue jump, touting operational wins ahead of federal reform. But a surprise CFO departure introduces a new variable.

NewLake Capital Partners reports stable Q2 results with 100% rent collection, deftly managing tenant restructuring while executing strategic growth.

As Organigram preps its Q3 results, all eyes are on its German expansion and its ability to defend its top spot in the competitive Canadian market.

Green Thumb Industries' new Hanover dispensary is more than retail growth. It's a calculated move in a key market, blending strategic expansion with a savvy model.

As NECANN returns to Atlantic City, it’s more than a trade show. It's the infrastructure for NJ's cannabis future, balancing profit with social repair.

As LEEF Brands preps its Q2 results, its soaring margins clash with a "going concern" warning, making it a crucial case study for survival in the state's cannabis market.

Jushi Holdings reports Q2 growth, buoyed by a landmark tax break and Virginia's new market. But a closer look at the balance sheet reveals significant debt.

Canadian cannabis giant SNDL acquires key U.S. assets in a complex deal, positioning itself to be one of the first Nasdaq-listed firms with direct U.S. operations.

A new partnership between data giant Alpine IQ and app developer Digital Awesome aims to solve retail's biggest challenge: turning loyalty members into loyal customers.

Cronos expands its top-selling SOURZ by Spinach® line, leveraging rare cannabinoids and seasonal flavors to defend its dominant share in Canada's complex market.

As Vireo becomes a top U.S. operator with its Cannabist asset buy, the deal reveals the brutal consolidation and strategic pivots defining the cannabis economy.

A product sold in gas stations is now a Schedule I drug in Kansas. How a legislative sleight of hand created a new class of felons and what it signals.

Standard Wellness is entering its hometown Cleveland market by divesting two historic dispensaries, a move that reveals a maturing, strategic Ohio cannabis industry.

While California's cannabis market struggles, MWG Holdings posts record growth. We explore their community-first model and data-driven tech defying industry trends.

Aurora Cannabis is the first of its kind on TIME's Best Companies list. We dissect the metrics—from finance to culture—to see if this is a PR coup or a new standard.

The wellness brand is leaving multi-level marketing behind for a new referral model. It’s a bold bet on authentic recommendations over recruitment.

Luxury resorts are embracing CBD, blending ancient hot springs with modern botanicals. But does the science support the hype, and what does this say about us?